Literature DB >> 6417024

Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

G I Byrne, D A Krueger.   

Abstract

Experiments were carried out to characterize immunologically mediated chlamydial persistence in cell culture. Mouse fibroblasts were activated to restrict Chlamydia psittaci 6BC replication by including mitogen (concanavalin A)-induced spleen cell supernatant fluids from immunized animals in the growth medium. When mouse fibroblasts were incubated with lymphokine for 24 h before infection and then with growth medium after infection (preinfection treatment), chlamydial replication was delayed but eventually detected. No substantial chlamydial growth occurred, even with extended incubation times when mouse fibroblasts were continuously exposed to lymphokine before and after infection. Low levels of infectious chlamydiae were produced in preinfection-treated mouse fibroblasts but not in mouse fibroblasts subjected to continuous lymphokine exposure. Incubation of lymphokine with anti-murine gamma interferon immunoglobulin neutralized the observed lymphokine-mediated activity, but incubation in the presence of anti-murine alpha plus beta interferon serum did not alter lymphokine activity. We conclude that the lymphokine components responsible for activating fibroblasts to restrict C. psittaci replication exhibits properties similar to gamma interferon.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6417024      PMCID: PMC264419          DOI: 10.1128/iai.42.3.1152-1158.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

Review 1.  The potential for vaccine against infection of the genital tract with Chlamydia trachomatis.

Authors:  J T Grayston; S P Wang
Journal:  Sex Transm Dis       Date:  1978 Apr-Jun       Impact factor: 2.830

2.  Fifteen-month follow-up study of women infected with Chlamydia trachomatis.

Authors:  W M McCormack; S Alpert; D E McComb; R L Nichols; D Z Semine; S H Zinner
Journal:  N Engl J Med       Date:  1979-01-18       Impact factor: 91.245

3.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

Authors:  C D Rothermel; B Y Rubin; H W Murray
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

4.  Psittacosis: the reservoir persists.

Authors:  J Schachter; N Sugg; M Sung
Journal:  J Infect Dis       Date:  1978-01       Impact factor: 5.226

Review 5.  Chlamydiae.

Authors:  J Schachter; H D Caldwell
Journal:  Annu Rev Microbiol       Date:  1980       Impact factor: 15.500

6.  Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis.

Authors:  C K Lee; J W Moulder
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Lymphokine-mediated microbistatic mechanisms restrict Chlamydia psittaci growth in macrophages.

Authors:  G I Byrne; C L Faubion
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

8.  Inhibition of Chlamydia psittaci in oxidatively active thioglycolate-elicited macrophages: distinction between lymphokine-mediated oxygen-dependent and oxygen-independent macrophage activation.

Authors:  G I Byrne; C L Faubion
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

9.  Differential susceptibility of chlamydiae to exogenous fibroblast interferon.

Authors:  G I Byrne; C D Rothermel
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form.

Authors:  J W Moulder; N J Levy; L P Schulman
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441

View more
  41 in total

Review 1.  Chlamydial persistence: beyond the biphasic paradigm.

Authors:  Richard J Hogan; Sarah A Mathews; Sanghamitra Mukhopadhyay; James T Summersgill; Peter Timms
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development.

Authors:  X Yang; R Brunham
Journal:  Can J Infect Dis       Date:  1998-03

Review 3.  Interaction of chlamydiae and host cells in vitro.

Authors:  J W Moulder
Journal:  Microbiol Rev       Date:  1991-03

4.  Identifying a role for Toll-like receptor 3 in the innate immune response to Chlamydia muridarum infection in murine oviduct epithelial cells.

Authors:  Wilbert A Derbigny; LaTasha R Shobe; Jasmine C Kamran; Katherine S Toomey; Susan Ofner
Journal:  Infect Immun       Date:  2011-10-17       Impact factor: 3.441

5.  Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response.

Authors:  Sanghamitra Mukhopadhyay; Richard D Miller; Erin D Sullivan; Christina Theodoropoulos; Sarah A Mathews; Peter Timms; James T Summersgill
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Inhibition of growth of Chlamydia trachomatis by human gamma interferon.

Authors:  Y Shemer; I Sarov
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

7.  Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice.

Authors:  J U Igietseme; I M Uriri; S N Kumar; G A Ananaba; O O Ojior; I A Momodu; D H Candal; C M Black
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Role of NK cells in early host response to chlamydial genital infection.

Authors:  C T Tseng; R G Rank
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

9.  Interferon-gamma inhibits growth of Coxiella burnetii in mouse fibroblasts.

Authors:  J Turco; H A Thompson; H H Winkler
Journal:  Infect Immun       Date:  1984-09       Impact factor: 3.441

10.  Gamma interferon production in response to homologous and heterologous strain antigens in mice chronically infected with Rickettsia tsutsugamushi.

Authors:  B A Palmer; F M Hetrick; T R Jerrells
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.